2020
DOI: 10.1111/dth.14407
View full text
|
Sign up to set email alerts
|
Share

Abstract: The efficacy of intravenous rituximab (RTX) in patients with pemphigus have been shown in the previous studies. The study aimed to investigate the effectiveness of intralesional injection of RTX in the healing of pemphigus lesions, with lower doses and probable better safety profile than intravenous RTX. Eleven Pemphigus patients with recalcitrant lesions received two intralesional injections of biosimilar RTX, 5 mg/cm 2. During 6 months follow-up, Pemphigus Disease Area Index, the patients' satisfaction, qual…

Expand abstract